My Account
Merck & Co
SYMBOL:MRK|SECTOR:Health Care|DERIVED:CFD
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices are indicative only and not appropriate for trading purposes. Therefore Moneycontrol doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
$35501
3
5
.
5
0
1
-1.40 (-1.31%)
As on 29 Mar, 2023 | 01:29 IST
Day Range
105.45
107.03
LH
52 Week Range
80.74
115.49
LH
| Open | 106.54 |
| Previous Close | 106.93 |
| Beta | 0.09 |
| High | 107.03 |
| Low | 105.45 |
| TTM EPS See historical trend | 7.48(+19.49% YoY) |
| 52 Week High | 115.49 |
| 52 Week Low | 80.74 |
| TTM PE See historical trend | 14.11(Average PE) |
| Mkt. Cap ($ Billion) | 267.51 |
| Dividend Yield | 3.20 |
Advance Chart
*Delayed by 20 seconds.
MC Technicals
Moving Averages
| Days | |
|---|---|
| 5 | 105.18 |
| 10 | 105.61 |
| 20 | 106.76 |
| 50 | 107.38 |
| 100 | 107.55 |
| 200 | 98.85 |
Returns
Price Performance
| 1 Week | -0.03% | |
| 1 Month | -0.69% | |
| 3 Months | -5.07% | |
| YTD | -4.82% | |
| 1 Year | 29.92% | |
| 3 Years | 47.09% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| J&J | 151.85 | -0.95 | 396.96 | 14.94 | 10.16 | 2.77 | 186.69/150.11 | -0.93 | Very Bearish |
| Eli Lilly | 337.65 | 0.91 | 320.75 | 41.73 | 8.09 | 1.21 | 384.44/276.83 | 8.47 | Bullish |
| AbbVie | 158.25 | 0.45 | 279.84 | 11.38 | 13.90 | 4.20 | 175.91/134.09 | 2.82 | Very Bullish |
| Merck & Co | 105.53 | -1.31 | 267.51 | 14.11 | 7.48 | 3.20 | 115.49/80.74 | -0.69 | Bearish |
| Pfizer | 39.98 | -0.60 | 224.48 | 6.03 | 6.63 | 3.66 | 56.32/39.23 | -1.43 | Very Bearish |
Market news
- S&P 500 ends up slightly; SVB deal lifts bank sharesMarch 28, 2023 6:04 AM
- Transparency and disclosure key to addressing risks to global financial stability, says IMF reportMarch 27, 2023 11:37 AM
- More than 900 members of American Chamber of Commerce in China no longer regard China as a top-three investment priorityMarch 26, 2023 3:36 PM
- Following close to $100 billion in deposit withdrawals, Jerome Powell reassures US banking system is safeMarch 26, 2023 9:26 AM
About the company
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.